Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
DXR
DXR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DXR News
European Stocks Set for Mixed Opening Amid Geopolitical Tensions
5d ago
CNBC
Daxor Reports 45% Year-over-Year Revenue Growth
6d ago
seekingalpha
Daxor Corporation Reports 2025 Financial and Technological Advancements
6d ago
Newsfilter
Geopolitical Crisis in the Middle East Impacts European Stocks
Mar 03 2026
CNBC
Trump's Global Tariff Policy Sparks Market Volatility
Feb 23 2026
CNBC
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available
Aug 12 2025
Newsfilter
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories
Aug 07 2025
TipRanks
Why Is Daxor Stock (DXR) Up 20% Today?
Aug 07 2025
TipRanks
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
Aug 07 2025
Newsfilter
Daxor's Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility Adoptions
Jul 22 2025
Newsfilter
Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
May 14 2025
Newsfilter
Three New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical Acceptance
May 06 2025
Newsfilter
Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
Apr 22 2025
Newsfilter
Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025
Apr 17 2025
Newsfilter
Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology's 74th Annual Scientific Session and Expo
Apr 02 2025
Newsfilter
Daxor Submits 510(k) To FDA For Next-Gen Blood Volume Analyzer
Apr 01 2025
NASDAQ.COM
Show More News
